KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Operating Leases (2019 - 2026)

Chemed filings provide 8 years of Operating Leases readings, the most recent being $104.4 million for Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases rose 2.32% year-over-year to $104.4 million, compared with a TTM value of $104.4 million through Mar 2026, up 2.32%, and an annual FY2025 reading of $102.9 million, up 4.39% over the prior year.
  • Operating Leases hit $104.4 million in Q1 2026 for Chemed, up from $102.9 million in the prior quarter.
  • The five-year high for Operating Leases was $110.5 million in Q4 2022, with the low at $98.5 million in Q4 2024.
  • Median Operating Leases over the past 5 years was $103.4 million (2022), compared with a mean of $103.8 million.
  • The sharpest move saw Operating Leases grew 10.43% in 2022, then fell 8.81% in 2023.
  • Year by year, Operating Leases stood at $110.5 million in 2022, then fell by 8.81% to $100.8 million in 2023, then decreased by 2.22% to $98.5 million in 2024, then rose by 4.39% to $102.9 million in 2025, then increased by 1.54% to $104.4 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods came in at $104.4 million, $102.9 million, and $99.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.